Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print November 20, 2008, DOI:10.2164/jandrol.108.005686
Journal of Andrology, Vol. 30, No. 3, May/June 2009
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.108.005686

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/3/248    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pickard, M. R.
Right arrow Articles by Williams, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pickard, M. R.
Right arrow Articles by Williams, G. T.

Preparation and Characterization of Prostate Cell Lines for Functional Cloning Studies to Identify Regulators of Apoptosis

MARK R. PICKARD*, DAVID DARLING{dagger}, FARZIN FARZANEH{dagger} AND GWYN T. WILLIAMS*

From the * Institute for Science and Technology in Medicine, Keele University, Keele, United Kingdom; and {dagger} King's College London, Department of Haematological Medicine, The Rayne Institute, London, United Kingdom.

Correspondence to: Professor G. T. Williams, Huxley Building, School of Life Sciences, Keele University, Keele ST5 5BG, United Kingdom (e-mail: g.t.williams{at}biol.keele.ac.uk).


Because apoptotic evasion is a central feature of prostate cancer, there is an urgent need for increased understanding of the key regulatory molecules that control the life/death decision of prostate cells. Functional expression cloning permits the isolation of genes that control the rate-limiting steps of cell death and offers a possible solution to this problem. This technique requires the availability of prostate cells that meet several stringent requirements. Therefore, the main objective was to obtain prostate cell clones that undergo cell death with minimal survival of spontaneously resistant cells and that can be infected at a high efficiency with viral vectors. Initial characterization of 5 prostate cell lines with a range of apoptotic inducers revealed cell line–dependent and treatment-dependent effects. In general, the colony-forming ability of nontumorigenic PNT2C2 cells showed the highest sensitivity to most chemical agents and ultraviolet (UV) irradiation, whereas the metastases-derived cell lines, LNCaP and PC-3, showed resistance to UV and etoposide, respectively. Clones of PNT2C2, 22Rv1, and PC-3 were produced, which displayed heterogeneous responses to UV irradiation. Further characterization of UV-sensitive clones revealed at least 1 clone per cell line with high sensitivity (mean clonogenic survival ≤0.02% control cells) to 3 or more apoptotic inducers. These clones could be infected at a high efficiency (>90%) with a lentiviral vector. In conclusion, we have isolated clones of nontumorigenic prostate cells (PNT2C2), androgen-sensitive prostate cancer cells (22Rv1), and androgen-independent, metastatic prostate cancer cells (PC-3), which are suitable as host cells for functional cloning studies to address cell death control mechanisms in the prostate during cancer progression.

     Key words: Cell death, prostate cancer, PNT2, 22Rv1, PC-3







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society of Andrology.